A practical, clinician-reviewed starting point for evaluating an AI vendor. Use this workflow to clarify responsibilities, keep people accountable for the record, and evaluate whether AI is helping in your particular setting.
Start with the job, not the tool
Before choosing an AI feature for evaluating an AI vendor, describe the current workflow in plain language. Who creates the information? Who relies on it? Where does it go next? A well-bounded task is easier to test and easier for staff to review than a broad instruction to “use AI for notes.”
AI can help shape a draft. The clinician and clinic remain responsible for deciding what belongs in the record.
A repeatable workflow
Use these steps as a discussion outline for evaluating an AI vendor, then adapt them to the tool, visit type, staffing model, and policies your organization has actually approved. Keep the workflow versioned so staff can find the current instructions.
- 01Write down the task, its intended audience, and what a complete result should contain. Keep evaluating an AI vendor separate from unrelated clinical work.
- 02Choose the source material and tool according to clinic policy. Use synthetic examples for early testing; do not enter patient information into an unapproved service.
- 03Give the responsible staff member a short checklist. Ask them to confirm accuracy, identify missing context, and flag statements that were not present in the source.
- 04Route the result through the clinic’s existing review and record-keeping process. Document who owns approval, what happens when something looks wrong, and when to stop.
- 05Test the workflow against ordinary and edge-case examples. Capture corrections and staff questions before deciding whether a template or policy needs to change.
- 06Set a follow-up date and compare a few practical measures. Continue only when the workflow is understandable, appropriately reviewed, and supported by the clinic’s normal approvals.
Privacy and the human review
HIPAA applicability and obligations depend on the organization, role, data, and arrangement. A tool label or de-identification prompt is not proof of compliance. Consult your privacy officer or qualified counsel; use HHS guidance as a starting point, not a substitute for a review.
Map the information flow before selecting a tool: identify the data, users, purpose, destinations, retention, subprocessors, and record-system boundary. Ask your privacy and security leads to evaluate the actual configuration and contract before any patient data is entered.
How to tell whether it helps
Maintain a current inventory of approved tools and use cases, completed risk reviews, access changes, vendor-term changes, training completion, and reported incidents or near misses.
Assuming that removing a name or asking an AI to anonymize text makes a dataset de-identified. Identifiers and contextual details can remain; use an approved method and have qualified personnel evaluate the result.
Before a pilot, a clinic maps a draft note from workstation to vendor to record system, asks who can access prompts and outputs, reviews retention and contract terms, and documents a decision with the privacy lead.
A closer look at evaluating an AI vendor
For evaluating an AI vendor, start with one representative example and trace each step from source to final documentation. Check that the output distinguishes patient-reported information, observed information, and clinician assessment where those distinctions matter. Make it easy to flag uncertainty instead of filling gaps.
A quick readiness check
- Is the tool and use case approved by the clinic?
- Does each role know what it may and may not do?
- Is there a clear reviewer and correction path?
- Can staff stop and escalate a privacy or safety concern?
- Are measures and a follow-up date defined?
Adapt the workflow to your clinic
A solo therapist, a multispecialty group, and a community clinic do not share the same staffing, records, or review paths. Keep the core safeguards, but specify local ownership, approved systems, accessible staff instructions, and a practical alternative when the AI workflow is unavailable or inappropriate.
Frequently asked questions
How should a clinic approach evaluating an AI vendor?
Map the information flow before selecting a tool: identify the data, users, purpose, destinations, retention, subprocessors, and record-system boundary. Ask your privacy and security leads to evaluate the actual configuration and contract before any patient data is entered.
Does HIPAA automatically approve or prohibit a particular AI tool?
HIPAA applicability and obligations depend on the organization, role, data, and arrangement. A tool label or de-identification prompt is not proof of compliance. Consult your privacy officer or qualified counsel; use HHS guidance as a starting point, not a substitute for a review.
What should staff review before using AI for evaluating an AI vendor?
Maintain a current inventory of approved tools and use cases, completed risk reviews, access changes, vendor-term changes, training completion, and reported incidents or near misses.
Make the next step easy to repeat
Give staff one current source of truth for evaluating an AI vendor: the approved tool, the workflow owner, the review checklist, and the escalation contact. Revisit it when the product, contract, law, clinical standard, or clinic process changes.
Continue with authoritative guidance
Use current primary sources alongside your organization’s policies and qualified advice.
This field guide is general educational information for US clinics and therapists. It does not establish HIPAA compliance or replace current legal, privacy, payer, or professional guidance. Confirm requirements with qualified people familiar with your organization and jurisdiction.